Santa Cruz Biotechnology features a diverse variety of Crry Antibodies for advanced research in immunology and cell biology. Crry Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Crry, or complement regulatory protein, plays a crucial role in the regulation of the complement system, which is essential for immune response and inflammation. By preventing the activation of complement components on host cells, Crry helps maintain self-tolerance and protects tissues from damage during immune responses. Understanding the function of Crry is vital for elucidating mechanisms of immune regulation and potential therapeutic targets in autoimmune diseases. Researchers worldwide rely on Crry monoclonal antibodies to investigate complement regulation pathways and their impact on immune system function. Crry monoclonal antibodies enable precise detection and analysis of complement regulatory mechanisms. Santa Cruz Biotechnology monoclonal antibodies for Crry support researchers in advancing scientific understanding of immune system regulation and developing new therapeutic strategies.